Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mate...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Emergency Department of Hospital San Pedro (Logroño, Spain)
2022-08-01
|
| Series: | Iberoamerican Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.iberoamjmed.com/article/doi/10.53986/ibjm.2022.0033 |